Market Cap 2.47B
Revenue (ttm) 1.36B
Net Income (ttm) 167.68M
EPS (ttm) N/A
PE Ratio 11.04
Forward PE 10.70
Profit Margin 12.32%
Debt to Equity Ratio 1.04
Volume 364,000
Avg Vol 935,674
Day's Range N/A - N/A
Shares Out 48.18M
Stochastic %K 77%
Beta 0.37
Analysts Strong Sell
Price Target $78.00

Company Profile

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLy...

Industry: Medical Devices
Sector: Healthcare
Phone: 781 848 7100
Address:
125 Summer Street, Boston, United States
JarvisFlow
JarvisFlow Oct. 21 at 4:12 PM
Barrington Research updates rating for Haemonetics ( $HAE ) to Outperform, target set at 86.
0 · Reply
D4RK_N1GHT
D4RK_N1GHT Oct. 20 at 8:11 PM
0 · Reply
Cutlass
Cutlass Oct. 8 at 7:42 PM
$HAE Creeping up the past 2 weeks 🪄
0 · Reply
JarvisFlow
JarvisFlow Oct. 7 at 5:06 PM
Citigroup has adjusted their stance on Haemonetics ( $HAE ), setting the rating to Buy with a target price of 78 → 64.
0 · Reply
Cutlass
Cutlass Oct. 3 at 4:14 PM
$HAE 👀
0 · Reply
healthcareguru
healthcareguru Sep. 30 at 3:42 PM
0 · Reply
JBr0
JBr0 Sep. 26 at 2:21 PM
$HAE Okay, I'm out. I don't like how this trades. Long term, I think folks are golden. However, the low volume, 111 percent "tute" ownership is killing me short term. I'm looking for quick trades right now....and yes I'm being very impatient....lol. Made a profit tho so that's a plus, but was hoping for more of a quick and significant pop. GL Bulls
1 · Reply
Cutlass
Cutlass Sep. 26 at 1:13 PM
$HAE Bought 48 -
0 · Reply
JBr0
JBr0 Sep. 25 at 8:01 PM
$HAE bought...
0 · Reply
johnmilnes
johnmilnes Sep. 25 at 7:46 PM
$HAE Gap fill from 2022
0 · Reply
Latest News on HAE
Haemonetics Corporation (HAE) Q1 2026 Earnings Call Transcript

Aug 9, 2025, 10:53 PM EDT - 2 months ago

Haemonetics Corporation (HAE) Q1 2026 Earnings Call Transcript


Haemonetics Corporation (HAE) Q4 2025 Earnings Call Transcript

May 10, 2025, 1:05 PM EDT - 6 months ago

Haemonetics Corporation (HAE) Q4 2025 Earnings Call Transcript


Haemonetics Announces Executive Leadership Updates

Mar 3, 2025, 4:10 PM EST - 8 months ago

Haemonetics Announces Executive Leadership Updates


Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 12:19 PM EST - 9 months ago

Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript


Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A

Jan 14, 2025, 6:13 AM EST - 10 months ago

Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A


Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A

Dec 3, 2024, 1:16 AM EST - 11 months ago

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A


Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript

May 10, 2024, 12:25 AM EDT - 1 year ago

Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript


Haemonetics Corporation Completes Acquisition of OpSens Inc.

Dec 12, 2023, 6:00 AM EST - 2 years ago

Haemonetics Corporation Completes Acquisition of OpSens Inc.


Haemonetics: Solid Performance Of This Blood Play

Nov 22, 2023, 6:15 AM EST - 2 years ago

Haemonetics: Solid Performance Of This Blood Play


JarvisFlow
JarvisFlow Oct. 21 at 4:12 PM
Barrington Research updates rating for Haemonetics ( $HAE ) to Outperform, target set at 86.
0 · Reply
D4RK_N1GHT
D4RK_N1GHT Oct. 20 at 8:11 PM
0 · Reply
Cutlass
Cutlass Oct. 8 at 7:42 PM
$HAE Creeping up the past 2 weeks 🪄
0 · Reply
JarvisFlow
JarvisFlow Oct. 7 at 5:06 PM
Citigroup has adjusted their stance on Haemonetics ( $HAE ), setting the rating to Buy with a target price of 78 → 64.
0 · Reply
Cutlass
Cutlass Oct. 3 at 4:14 PM
$HAE 👀
0 · Reply
healthcareguru
healthcareguru Sep. 30 at 3:42 PM
0 · Reply
JBr0
JBr0 Sep. 26 at 2:21 PM
$HAE Okay, I'm out. I don't like how this trades. Long term, I think folks are golden. However, the low volume, 111 percent "tute" ownership is killing me short term. I'm looking for quick trades right now....and yes I'm being very impatient....lol. Made a profit tho so that's a plus, but was hoping for more of a quick and significant pop. GL Bulls
1 · Reply
Cutlass
Cutlass Sep. 26 at 1:13 PM
$HAE Bought 48 -
0 · Reply
JBr0
JBr0 Sep. 25 at 8:01 PM
$HAE bought...
0 · Reply
johnmilnes
johnmilnes Sep. 25 at 7:46 PM
$HAE Gap fill from 2022
0 · Reply
dkkstocks
dkkstocks Sep. 25 at 7:35 PM
$HAE relentless selloff.
0 · Reply
JarvisFlow
JarvisFlow Sep. 23 at 3:10 PM
Barrington Research has adjusted their stance on Haemonetics ( $HAE ), setting the rating to Outperform with a target price of 86.
0 · Reply
D4RK_N1GHT
D4RK_N1GHT Sep. 19 at 3:21 PM
0 · Reply
Cutlass
Cutlass Sep. 17 at 3:24 PM
$HAE 50.00 filled today 📋
0 · Reply
healthcareguru
healthcareguru Sep. 17 at 2:56 PM
$HAE this is completely stupid…insanely oversold, dirt cheap at 10x fwd P/E, guidance intact, massive squeeze setup for FY2Q coming up…back to $70. 👍 $IWM $IHI $XLV
0 · Reply
Lotzlizard
Lotzlizard Sep. 17 at 2:16 PM
$HAE Finally got my shares at 50.32!!! Let’s go
0 · Reply
healthcareguru
healthcareguru Sep. 15 at 2:57 PM
$HAE Stupid oversold with clear upside to FY2Q number son deck…beat/raise (or even maintain at these levels) => SQUEEZE CITY. Buyer. 👍 $IHI $XLV $IWM $XBI
0 · Reply
RedSurge
RedSurge Sep. 15 at 9:45 AM
$HAE Cost structure pressure possible; watch productivity initiatives
0 · Reply
Cutlass
Cutlass Sep. 12 at 7:09 PM
$HAE Bought 52.15 📋
0 · Reply
D4RK_N1GHT
D4RK_N1GHT Sep. 10 at 12:59 PM
0 · Reply
N0_Brainers
N0_Brainers Sep. 9 at 5:45 PM
$HAE buying
0 · Reply
MacroVoyager
MacroVoyager Aug. 27 at 7:05 AM
$HAE gradually climbing, but watch for sharp reversals.
0 · Reply